Nexstem Raises $3.5 Million to Accelerate Development of BCI Solutions, Disrupting the Neurotech Sector
InfoEdge, Gruhas, Zupee and Smile Group are leading the investment
The funding will drive Nexstem to scale operations for its latest product – Instinct Ecosystem, enhance its IP portfolio and presence in American and European markets
The capital will accelerate the deployment of Nexstem’s biosignal infrastructure with an advanced Brain Computer Interface (BCI) suite, making non-invasive neurotech solutions accessible across sectors apart from healthcare
The company aims to create a digital nervous system that records and interprets biosignals, enabling direct human body-to-technology communication to restore lost capabilities like prosthetic limbs control or enhance human abilities like peak performances and telepathy
Bengaluru-based deep-tech startup Nexstem, a pioneer in developing cutting-edge non-invasive Brain Computer Interface (BCI) solutions, has raised $3.5 million in its latest funding round. The funding round attracted prominent investors, such as InfoEdge, Zupee, Smile Group and Nikhil Kamath & Abhijeet Pai’s Gruhas. This investment will help Nexstem scale its latest product ecosystem, and expand its IP portfolio, leading to disruption in the neurotech sector.
Nexstem’s breakthrough product suite for BCI – Instinct leverages a unique AI-powered onboard compute module that supports analysis for all kinds of biosignals from the human body. BCI technology essentially enables direct communication between the human brain and external devices, a field once confined to science fiction but now rapidly advancing toward real-world applications. From restoring lost motor functions to augmenting cognitive capabilities, BCI has the pote
